In reproductive medicine, NGS is revolutionizing preimplantation genetic testing (PGT) by allowing for the comprehensive chromosomal analysis of embryos. This technology helps in detecting aneuploidies and single-gene disorders, thereby increasing the success rates of IVF cycles and reducing the risk of genetic disorders in offspring. Additionally, NGS can identify genetic factors contributing to recurrent pregnancy loss and infertility, guiding personalized treatment plans.